Is There a Rationale for the Use of an Alpha-Melanocyte-Stimulating Hormone Analog to Improve Gray Hair Repigmentation?

    November 2022 in “ Skin Appendage Disorders
    Daniel Fernandes Melo, Sandra Tagliolatto, Ana Cecília Studart, Bruna Fanton Gallo, Carla Jorge Machado, Simone Carolina Frattini, Flávia Weffort, Rita Fernanda Cortez de Almeida
    Studysummary This study found that a 6-month treatment with 2% palmitoyl tetrapeptide 20 showed no significant improvement in reducing hair graying in patients, despite theoretical potential.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results